Development of new nano-immunotherapy could transform patient care and provide a solution to the problems hindering success of transplants. Transplanted organs can be rejected by the body when innate immune cells called myeloid cells induce T-cells to attack it. To prevent this immune response, patients must take drugs that suppress this T-cell activity, but this
New research suggests that a regulator protein, AP2-G, could hold the key to finding new ways to prevent malaria. The team behind the work, from the University of Glasgow and the Wellcome Sanger Institute, designed a new experimental system to investigate, in detail, the role of AP2-G in the Plasmodium parasite’s life. Scientists found that
The new Cancer Research UK City of London Centre has set its sights on a unique research focus, with the belief that biotherapeutics will become vitally important in future cancer treatments. The centre aim to attract millions in capital investment and will boost the biotechnology economy in London as new companies are formed, and industry
